SynthesisFrontiers in neurology2026
Implications and prospects of immunological and neuroimaging research in HIV-associated neurocognitive disorders.
Synthesis in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Combination antiretroviral therapy effectively controls viral replication in HIV-infected individuals, yet cognitive and motor impairments persist in 30-60% of patients, contributing to HIV-associated neurocognitive disorders (HAND). Current diagnostic approaches, such as the Frascati criteria, remain limited by practicality and sensitivity. Integrating neuroimaging with immunological markers may enhance early detection and mechanistic understanding. Methods: We conducted a literature search in PubMed and Web of Science for articles published between 1990 and 2024, using keywords including "HIV-associated neurocognitive disorders," "HIV," "immunity," "neuroimaging," and "treatment." Additional relevant publications were identified through manual review of reference lists. Results: This review synthesizes current epidemiology, diagnostic methods, and neuroimmune mechanisms underlying HAND. It summarizes available neuroimaging techniques and associated biomarkers, emphasizing progress in combining neuroimaging with immunology to identify structural and functional neural changes. Abnormal neuroimaging findings coupled with immunological markers show promise for earlier detection compared to cognitive assessments alone. Discussion: We highlight the systemic connections between early HAND diagnosis and the synergistic use of neuroimaging and immunology, identifying candidate biomarkers in HAND pathogenesis. Furthermore, we discuss emerging treatment strategies and the relevance of early detection in the context of potential HIV eradication.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.